Hear the latest information from our expert speaker panel to help you understand the changes that are required and ensure you are up to date with Brexit!
18 Mar 2019
GBP 699 599 *
EUR 979 839 *
USD 1,090 934 *
* When you book before 15 Feb
With Britain’s exit from the European Union fast approaching, the new arrangements for all aspects of the regulation of pharmaceuticals, medical devices and IVDs between the UK and EU 27 pose major challenges.
The ramifications of Brexit after more than 40 years of ever-deepening integration and alignment across the life science sector will be immense, whatever final form Brexit takes.
This course will enable you to hear the latest information from our expert panel of speakers to help you understand the changes that are required and ensure you are ready as the deadlines approach.
Benefits of attending:
This course will be of interest to anyone within the pharmaceutical or medical technology sectors seeking an update on the impact of Brexit.
Brexit – the MHRA perspective
Question and answer session
The medical technology sector – what are the issues and how to operate from 30/3/19
The pharma sector – what actions need to be taken to prepare for Brexit
How to operate in the UK post Brexit
Final discussion session